Skip to content

Aptima®

by Hologic 5 variants

Ref PRD-07881

Aptima (ASY-17189) is a SARS-CoV-2 nucleic acid IVD (EU IVDR Class B; FDA Class II; FDA product code QQX, Respiratory specimen nucleic acid SARS-CoV-2 test) made by Hologic, registered in EUDAMED on 9 Jul 2026 (Basic UDI-DI 54200455DIAGAPTSARSCOV2CC), cleared under FDA 510(k) K243396 on 13 Feb 2025 and listed in FDA GUDID since 14 Mar 2025 (UDI-DI 15420045516991), active as of 25 Oct 2026.

Active European Union and United States. Also listed in GUDID (US).

CE IVDR 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

None found

in data synced 25 Oct 2026

Documents

None linked in EUDAMED

A group certificate may exist

510(k) K243396

FDA submission, from GUDID

Trust

Unverified

Source EUDAMED, GUDID, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDR EUDAMED Number54200455DIAGAPTSARSCOV2CC Basic UDI-DI 15420045516991UDI-DIDate9 Jul 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number15420045516991 UDI-DI Date14 Mar 2025ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Traditional NumberK243396 Date13 Feb 2025DecidedStatusActive

Official records

From the FDA record

Device description
Aptima® SARS-CoV-2 Assay, 100 test, box 1 of 2 (2°C to 8°C box).
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 25 Oct 2026, as the labeller entered it.

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI 54200455DIAGAPTSARSCOV2CC registered 9 Jul 2026 Active
  • FDA 510(k) K243396 decided 13 Feb 2025 Active
  • FDA GUDID UDI-DI 15420045516991 listed 14 Mar 2025 Listed

Timeline

3 dated events

  1. Cleared FDA 510(k) K243396
  2. Listed FDA GUDID 15420045516991
  3. Registered EUDAMED 54200455DIAGAPTSARSCOV2CC

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Aptima SARS-CoV-2 Assay EUDAMED
Aptima® GUDID
Generic name
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
Model / Ref / Catalog
PRD-07881 EUDAMED
BOX 1 GUDID
REFRIG GUDID
SARS-COV-2 ASSAY GUDID
APTIMA 100T GUDID
IVD GUDID
ASY-17189 GUDID
Primary DI / UDI-DI
15420045516991
Basic UDI-DI
54200455DIAGAPTSARSCOV2CC
Direct marketing DI
15420045516991
510(k) Number
FDA product code
QQX
EMDN code
W0105041106 Coronavirus - na reagents
GMDN term
SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
Device class
Class B EUDAMED
Class II GUDID
Regulation number
866.3981
EU registration type
Standard device
EU market of registration
Belgium
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 2 fields differ

FieldEUDAMEDGUDID
Model / referenceEUDAMED
PRD-07881
GUDID
BOX 1, REFRIG, SARS-COV-2 ASSAY, APTIMA 100T, IVD
Device classEUDAMED
Class B
GUDID
Class II

Device class is stated on each registry's own scale: Class B in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under CORONAVIRUS - NA REAGENTS.

Other devices from Hologic

See all devices from Hologic →

Properties

  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (20, all answered No)